41.96
price up icon3.71%   1.50
after-market アフターアワーズ: 41.96
loading
前日終値:
$40.46
開ける:
$40.38
24時間の取引高:
900.01K
Relative Volume:
0.93
時価総額:
$2.82B
収益:
$2.82B
当期純損益:
$-1.87B
株価収益率:
-1.5039
EPS:
-27.9
ネットキャッシュフロー:
$-96.80M
1週間 パフォーマンス:
+3.43%
1か月 パフォーマンス:
-5.15%
6か月 パフォーマンス:
-6.78%
1年 パフォーマンス:
-10.51%
1日の値動き範囲:
Value
$40.38
$42.06
1週間の範囲:
Value
$39.90
$42.50
52週間の値動き範囲:
Value
$29.73
$49.45

Quidelortho Corporation Stock (QDEL) Company Profile

Name
名前
Quidelortho Corporation
Name
セクター
Healthcare (1168)
Name
電話
(858) 552-1100
Name
住所
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Name
職員
7,100
Name
Twitter
@QuidelDX
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
QDEL's Discussions on Twitter

QDEL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
QDEL
Quidelortho Corporation
41.96 2.82B 2.82B -1.87B -96.80M -27.90
Medical Devices icon
ABT
Abbott Laboratories
134.95 234.06B 41.95B 13.40B 6.49B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
104.39 154.06B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
387.92 148.02B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
90.17 115.71B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.76 42.91B 5.72B 4.17B 490.10M 6.97

Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-11 アップグレード Citigroup Neutral → Buy
2024-12-10 開始されました Jefferies Hold
2024-09-19 再開されました UBS Neutral
2024-09-05 アップグレード Craig Hallum Hold → Buy
2024-03-04 ダウングレード UBS Neutral → Sell
2024-02-14 ダウングレード JP Morgan Neutral → Underweight
2023-12-11 ダウングレード Citigroup Buy → Neutral
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Outperform
2022-10-14 アップグレード UBS Sell → Neutral
2022-09-19 開始されました Citigroup Neutral
2022-07-20 開始されました UBS Sell
2022-06-17 再開されました JP Morgan Neutral
2022-02-22 アップグレード Raymond James Outperform → Strong Buy
2021-01-22 アップグレード Raymond James Mkt Perform → Outperform
2020-05-12 ダウングレード JP Morgan Neutral → Underweight
2020-03-26 ダウングレード Barclays Overweight → Equal Weight
2018-10-23 再開されました Raymond James Strong Buy
2018-03-08 アップグレード Raymond James Outperform → Strong Buy
2018-01-22 繰り返されました Barclays Overweight
2018-01-04 アップグレード CL King Neutral → Buy
2017-09-19 アップグレード Piper Jaffray Neutral → Overweight
2017-07-18 アップグレード Canaccord Genuity Hold → Buy
2017-07-18 アップグレード William Blair Mkt Perform → Outperform
2017-04-25 繰り返されました Canaccord Genuity Hold
2017-02-17 開始されました CL King Neutral
2016-12-16 ダウングレード Piper Jaffray Overweight → Neutral
2016-06-13 アップグレード Raymond James Mkt Perform → Outperform
2016-02-18 繰り返されました Barclays Overweight
2016-02-09 ダウングレード Canaccord Genuity Buy → Hold
2016-01-08 繰り返されました Canaccord Genuity Buy
2015-12-14 ダウングレード Raymond James Outperform → Mkt Perform
2015-09-02 開始されました Barclays Overweight
2013-07-31 繰り返されました Canaccord Genuity Buy
2011-03-03 ダウングレード Wedbush Outperform → Neutral
すべてを表示

Quidelortho Corporation (QDEL) 最新ニュース

pulisher
Feb 24, 2025

Inside QuidelOrtho's Growth Strategy: Key Insights Coming at Raymond James Conference - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Transfusion Medicine Business Development ManagerSouth Arkansas, Mississippi,and Louisiana - CollegeRecruiter.com

Feb 23, 2025
pulisher
Feb 21, 2025

QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 – QDEL - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

QuidelOrtho Co. (NASDAQ:QDEL) Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors - Seeking Alpha

Feb 20, 2025
pulisher
Feb 20, 2025

$30+ Bn Primary Care POC Diagnostics Market Opportunities - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

Why QuidelOrtho Stock Bounced More Than 4% Higher Today - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

QDEL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Feb 19, 2025
pulisher
Feb 19, 2025

QuidelOrtho Co. (NASDAQ:QDEL) Sees Significant Decrease in Short Interest - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.

Feb 19, 2025
pulisher
Feb 19, 2025

January 2026 Options Now Available For QuidelOrtho (QDEL) - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

QuidelOrtho Co. (NASDAQ:QDEL) Receives $51.20 Average PT from Analysts - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024 - MSN

Feb 19, 2025
pulisher
Feb 18, 2025

QuidelOrtho's SWOT analysis: stock poised for growth amid challenges - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Stephens Inc. AR Acquires Shares of 14,915 QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

QDEL DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho (NASDAQ:QDEL) Trading Down 4.9% Following Analyst Downgrade - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho (NASDAQ:QDEL) Shares Gap Up Following Analyst Upgrade - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho (NASDAQ:QDEL) Price Target Raised to $45.00 - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

18,856 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by Legato Capital Management LLC - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho (NASDAQ:QDEL) Cut to Hold at StockNews.com - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Feb 17, 2025
pulisher
Feb 17, 2025

QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 17, 2025

QuidelOrtho (NASDAQ:QDEL) Issues FY 2025 Earnings Guidance - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

QuidelOrtho (NASDAQ:QDEL) Issues Quarterly Earnings Results, Misses Estimates By $0.44 EPS - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

QuidelOrtho projects $2.6B-$2.81B revenue for 2025 supported by cost savings and margin expansion - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

QuidelOrtho (NASDAQ:QDEL) Announces Quarterly Earnings Results - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

QuidelOrtho 2025 EPS, revenue guidance ranges include consensus - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

QuidelOrtho Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St

Feb 14, 2025
pulisher
Feb 14, 2025

Lightrock Netherlands B.V. Takes $10.05 Million Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2024 Earnings Call Transcript - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Bus. Run on... - br.ADVFN.com

Feb 13, 2025
pulisher
Feb 13, 2025

QuidelOrtho’s Earnings Call: Mixed Sentiment Amidst Revenue Decline - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

QDELQuidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics - br.ADVFN.com

Feb 13, 2025
pulisher
Feb 13, 2025

Where QuidelOrtho Stands With Analysts - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract - Yahoo Finance

Feb 13, 2025
pulisher
Feb 13, 2025

UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating - Marketscreener.com

Feb 13, 2025

Quidelortho Corporation (QDEL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices ZBH
$105.98
price up icon 1.10%
medical_devices STE
$223.68
price up icon 1.41%
medical_devices PHG
$25.98
price up icon 1.68%
$90.75
price up icon 2.22%
$90.57
price down icon 0.57%
medical_devices EW
$72.76
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):